NCT01737372 A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis Status COMPLETED Phase N/A
NCT01728922 Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome Status COMPLETED Phase PHASE1/PHASE2
NCT01723709 The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort Status COMPLETED Phase N/A
NCT01723631 Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis Status TERMINATED Phase NA
NCT01720849 Efficiency of 4-aminopyridin (Fampyra) on Gait, Vision, Cognition, Fatigue and Micturation in Patients With Multiple Sclerosis Status UNKNOWN Phase N/A
NCT01718392 Rehabilitation in Multiple Sclerosis: Influence of Exercise on Development of Insulin Resistance, Muscle Power and Aerobic Capacity Status COMPLETED Phase NA
NCT01712945 Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis Status TERMINATED Phase PHASE1/PHASE2
NCT01707992 The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Status COMPLETED Phase PHASE3
NCT01706055 Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE) Status COMPLETED Phase N/A
NCT01698086 Vestibular Rehabilitation for Persons With Multiple Sclerosis: Who Benefits the Most? (MSVR3trial) Status COMPLETED Phase NA
NCT01695434 A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months Status COMPLETED Phase N/A
NCT01684761 Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01679041 High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment Status TERMINATED Phase PHASE2
NCT01667484 Adderall XR and Processing Speed in Multiple Sclerosis (MS) Status COMPLETED Phase PHASE2/PHASE3
NCT01659593 Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients Status UNKNOWN Phase NA
NCT01658384 Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients Status COMPLETED Phase N/A